Delivery Order SPE2DB20D1110-SPE2DB24FJ87R
Award Date 1/18/24
Potential Completion Date 1/19/24
Potential Value $2.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,119.54, is for the delivery of valsartan-HCTZ 160-25 mg tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This IDC with the DLA Troop Support Medical serves as the...
- This federal contract award, valued at $1,789.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. This award is not designated under any set-aside program. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and...
- This federal contract award, valued at $2,051.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count packages, with an ultimate completion date of April 17, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $1,965.97, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., also doing business as Amerisourcebergen. This IDC, valued at up to...
- This federal contract award, valued at $3,708.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,160,810 units of the medication Valsartan-HCTZ 320-25 mg tablets in 90-count packages. The contract has a completion date of May 7, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,614.28, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award, valued at $2,384.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of Valsartan-HCTZ 160-12.5 mg tablets, which are used to treat high blood pressure. The contract has an ultimate completion date of March 21, 2024 and is a firm fixed-price contract. The award was not designated with a set-aside requirement,...
- This federal contract award, valued at $8,434.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-Hctz 160-12.5 mg tablets in quantities of 90 per bottle. This is a firm fixed-price delivery order contract with a completion date of May 24, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
- This federal contract award for $11,637.96 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Valsartan-HCTZ 160-25 mg tablets. The order was issued as a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total ceiling value of up to $999,999,999 through December 2025. The contract does not utilize a set-aside designation and is for a firm fixed-price...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,330.36, is a delivery order for Valsartan-HCTZ 160-12.5 mg tablets. It is a firm fixed price contract with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and this award is part of a larger...